<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Training Together, Diagnosing Better: Federated Learning for Collagen VI-Related Dystrophies - Health AI Hub</title>
    <meta name="description" content="This paper presents a novel application of Federated Learning (FL) to address the challenge of data scarcity and privacy in diagnosing rare diseases, specifical">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Training Together, Diagnosing Better: Federated Learning for Collagen VI-Related Dystrophies</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.16876v1" target="_blank">2512.16876v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-18
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Astrid Brull, Sara Aguti, V√©ronique Bolduc, Ying Hu, Daniel M. Jimenez-Gutierrez, Enrique Zuazua, Joaquin Del-Rio, Oleksii Sliusarenko, Haiyan Zhou, Francesco Muntoni, Carsten G. B√∂nnemann, Xabi Uribe-Etxebarria
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.LG, cs.AI, cs.CV, cs.DC
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.98 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.16876v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.16876v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper presents a novel application of Federated Learning (FL) to address the challenge of data scarcity and privacy in diagnosing rare diseases, specifically Collagen VI-related dystrophies (COL6-RD). By enabling collaborative model training across decentralized datasets from two international organizations using immunofluorescence microscopy images, the study developed an ML model that achieved an F1-score of 0.82 for classifying COL6-RD pathogenic mechanisms, significantly outperforming single-institution models.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is highly relevant as it offers a practical and privacy-preserving solution to leverage fragmented data for rare disease diagnosis, which is typically hindered by limited patient cohorts. It paves the way for more accurate and widely applicable diagnostic tools, improving patient care for complex and often misdiagnosed conditions.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI application is Federated Learning (FL) used to develop a more accurate and generalizable machine learning model for the diagnosis and subtyping of Collagen VI-Related Dystrophies (COL6-RD). FL enables collaborative model training across decentralized, private datasets from multiple institutions, overcoming data scarcity and privacy barriers inherent in medical research. This model classifies patient immunofluorescence microscopy images into specific pathogenic mechanism groups (exon skipping, glycine substitution, pseudoexon insertion), thereby improving diagnostic utility and supporting clinical genetic interpretation.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the fundamental limitation of Machine Learning (ML) in rare disease diagnosis due to data scarcity, fragmentation, and severe privacy/regulatory obstacles.</li>
                    
                    <li>Proposes Federated Learning (FL) as a promising solution, allowing collaborative model training across decentralized datasets while keeping patient data local and private.</li>
                    
                    <li>Implemented a novel global FL initiative using the Sherpa.ai FL platform, leveraging data from two international organizations.</li>
                    
                    <li>Focused on the diagnosis of Collagen VI-related dystrophies (COL6-RD) using collagen VI immunofluorescence microscopy images from patient-derived fibroblast cultures.</li>
                    
                    <li>The resulting ML model successfully classified COL6-RD patient images into three primary pathogenic mechanism groups: exon skipping, glycine substitution, and pseudoexon insertion.</li>
                    
                    <li>Achieved a high F1-score of 0.82, demonstrating superior performance compared to isolated single-organization models (F1-scores ranging from 0.57 to 0.75).</li>
                    
                    <li>The findings indicate that FL substantially improves diagnostic utility and generalizability for rare disease models compared to traditional centralized or siloed approaches.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study employed a Federated Learning (FL) approach using the Sherpa.ai FL platform. An ML model was collaboratively trained across decentralized datasets from two international organizations. The input data consisted of collagen VI immunofluorescence microscopy images derived from patient fibroblast cultures, which the model was trained to classify into three specific pathogenic mechanism groups associated with COL6-RD.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The Federated Learning model achieved a high diagnostic performance with an F1-score of 0.82 for classifying COL6-RD pathogenic mechanisms from microscopy images. This significantly outperformed models trained in isolation on single-organization datasets, which yielded F1-scores between 0.57 and 0.75. This demonstrates that FL substantially enhances diagnostic utility and generalizability.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This FL approach offers a more accurate and generalizable diagnostic tool for COL6-RD, potentially leading to earlier and more precise diagnoses. It can also support the interpretation of variants of uncertain significance (VUS) and guide the prioritization of sequencing strategies, thereby facilitating the identification of novel pathogenic variants and improving patient management in rare disease clinics.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly detail specific limitations of this particular study. However, it frames the work as overcoming the general limitations of ML in rare disease diagnosis, such as data scarcity, fragmentation, and privacy concerns, which FL directly addresses.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The authors anticipate that this FL approach will support the interpretation of variants of uncertain significance and guide the prioritization of sequencing strategies to identify novel pathogenic variants. This implies future applications in genetic diagnostics, variant annotation, and personalized medicine for rare diseases.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Neuromuscular Disorders</span>
                    
                    <span class="tag">Genetics</span>
                    
                    <span class="tag">Pathology</span>
                    
                    <span class="tag">Medical Imaging</span>
                    
                    <span class="tag">Rare Disease Diagnostics</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Federated Learning</span>
                    
                    <span class="tag tag-keyword">Rare Diseases</span>
                    
                    <span class="tag tag-keyword">Collagen VI Dystrophies</span>
                    
                    <span class="tag tag-keyword">Machine Learning</span>
                    
                    <span class="tag tag-keyword">Immunofluorescence Microscopy</span>
                    
                    <span class="tag tag-keyword">Privacy-Preserving AI</span>
                    
                    <span class="tag tag-keyword">Diagnostic Utility</span>
                    
                    <span class="tag tag-keyword">Precision Medicine</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">The application of Machine Learning (ML) to the diagnosis of rare diseases, such as collagen VI-related dystrophies (COL6-RD), is fundamentally limited by the scarcity and fragmentation of available data. Attempts to expand sampling across hospitals, institutions, or countries with differing regulations face severe privacy, regulatory, and logistical obstacles that are often difficult to overcome. The Federated Learning (FL) provides a promising solution by enabling collaborative model training across decentralized datasets while keeping patient data local and private. Here, we report a novel global FL initiative using the Sherpa.ai FL platform, which leverages FL across distributed datasets in two international organizations for the diagnosis of COL6-RD, using collagen VI immunofluorescence microscopy images from patient-derived fibroblast cultures. Our solution resulted in an ML model capable of classifying collagen VI patient images into the three primary pathogenic mechanism groups associated with COL6-RD: exon skipping, glycine substitution, and pseudoexon insertion. This new approach achieved an F1-score of 0.82, outperforming single-organization models (0.57-0.75). These results demonstrate that FL substantially improves diagnostic utility and generalizability compared to isolated institutional models. Beyond enabling more accurate diagnosis, we anticipate that this approach will support the interpretation of variants of uncertain significance and guide the prioritization of sequencing strategies to identify novel pathogenic variants.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>